Back to search

Article

Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology

2026-07-09

Abstract excerpt

<h4>SUMMARY</h4> Genomics-guided precision oncology has improved survival in cancer entities with actionable mutations but cannot capture oncogenic signaling that manifests at the protein level. Here, we report a prospective, real-world pan-cancer study profiling proteomes and phosphoproteomes of 1,998 tumor samples from adults and children with rare or advanced cancers enrolled in the German precision oncology p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
63eb8414-b7d3-5ed5-b900-3d0df0628052
DOI
10.64898/2026.07.08.737171
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncologyDOI 10.64898/2026.07.08.737171
Select a neighboring publication to make it the new centre.